by Stacey Johnson | Jan 15, 2016
It was huge news in Canada on Wednesday (January 13) when the Centre for Commercialization of Regenerative Medicine (CCRM) and GE Healthcare announced their partnership in the development of a new centre for advanced therapeutic cell technologies. GE Healthcare is...
by Stacey Johnson | Jan 8, 2016
Jakub Tolar, the University of Minnesota researcher who shared stage time with Pearl Jam’s Eddie Vedder, has been awarded $2.4 million, by the Schulze Family Foundation, to support his work creating new skin for people suffering from burns and skin diseases, such as...
by Mark Curtis | Dec 30, 2015
Welcome to your Cell Therapy Deal Review for the month of November. Astellas failed to achieve the majority share it needed to push through a takeover of Ocata Therapeutics valued at $379 million. ImmunoCellular Therapeutics announced a research agreement with MD...
by Stacey Johnson | Dec 4, 2015
Justin Trudeau, Canada’s “hot” new prime minister, is getting Canadian scientists all worked up – in a good way. For the first time in nearly ten years, the scientific community has a passionate champion in Ottawa ready to undress – sorry unmuzzle – federal scientists...
by Nicole Kuchinsky | Dec 1, 2015
November was a big month for science in Canada. Our new prime minister, Justin Trudeau, sent a clear message that science will be a priority for his administration by naming Dr. Kirsty Duncan Minister of Science, and Navdeep Bains Minister of Innovation, Science and...
by Mark Curtis | Nov 24, 2015
Welcome to your Cell Therapy Deal Review for the month of October. Lion Biotechnologies and Kite Pharma both made deals with the National Institutes of Health (NIH) that significantly expanded their respective pipelines. Kite also announced a research collaboration...
Comments